A carregar...
On the Site and Mechanism of Action of β(3)-Adrenoceptor Agonists in the Bladder
The clinical success of mirabegron as the first β(3)-adrenoceptor (AR) agonist for treatment of the overactive bladder (OAB) syndrome, has resulted in substantial interest in its site and mechanism of action. Even if the adrenergic innervation of the bladder and urethra has been well studied, the lo...
Na minha lista:
| Publicado no: | Int Neurourol J |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Continence Society
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5380826/ https://ncbi.nlm.nih.gov/pubmed/28361520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5213/inj.1734850.425 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|